Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.

Bladder cancer (BC) is a common genitourinary malignancy worldwide. However, the molecular pathogenesis of BC remains unclear. The current study conducted bioinformatic analyses to discover key genes involved in BC progression. A total of 375 differentially expressed genes (DEGs) were screened in the GEO database and The Cancer Genome Atlas (TCGA) database, which were further evaluated by the core level in the protein-protein interaction network. (Rac family small GTPase 3), one of the top hub genes, was focused on for its gene expression and prognostic value in BC. Immunohistochemical assays indicated elevated levels in BC tissues compared with normal tissues. Overexpression of expression was closely associated with poor differentiation ( = 0.035), advanced TNM stage ( = 0.014), lymph metastasis ( = 0.033), and recurrence ( < 0.001). Kaplan-Meier and Cox proportional hazards analyses demonstrated that high expression indicated poor survival of BC patients, which could serve as an independent prognostic factor for overall survival (HR = 3.159,  = 0.023) and disease-free survival (HR = 4.633,  = 0.002). Moreover, bioinformatic analyses indicated that might be correlated with malignant phenotypes and immune infiltration of BC. Taken together, could be a novel prognostic biomarker for BC.